Patents by Inventor Markus Johann BAUER

Markus Johann BAUER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LRP5 and PD-1 antagonist anticancer combination therapy
    Patent number: 11578129
    Abstract: The invention describes anti-cancer therapies comprising using an LRP5 antagonist in combination with an anti-PD1 antibody, each as described herein.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: February 14, 2023
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Vittoria Zinzalla, Markus Johann Bauer, Barbara Drobits-Handl
  • ANTICANCER COMBINATION THERAPY
    Publication number: 20200308283
    Abstract: The invention describes anti-cancer therapies comprising using an LRP5 antagonist in combination with an anti-PD1 antibody, each as described herein.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: Vittoria ZINZALLA, Markus Johann BAUER, Barbara DROBITS-HANDL
  • ANTICANCER COMBINATION THERAPY
    Publication number: 20200308276
    Abstract: The invention describes anti-cancer therapies comprising using an polypeptide capable of specifically binding to LRP5 and LRP6 in combination with an anti-PD1 antibody, each as described herein.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: Vittoria ZINZALLA, Markus Johann BAUER, Barbara DROBITS-HANDL